BMJ-BRIT MED J 润色咨询

BMJ-British Medical Journal

出版年份：暂无数据 年文章数：1625 投稿命中率： 开通期刊会员，数据随心看

出版周期：Weekly 自引率：6.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：文章已接受，版面Endgames，请问大侠们Endgames版面从接受到proof需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：方法学;临床流行病<br>经验分享：审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天，状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向：循证医学;流行病学<br>经验分享：投稿两个月了，还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享：已投七个月，返修两次，现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享：投稿两月余，这段时间awaiting reviewer scores后变成 with with committee for evaluation，后来两天又变成awaiting reviewer scores，大侠们知道什么情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿，邮件时间一个月，系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿，邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改，时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑，目前等待proof，感谢一起努力的三位伙伴，铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向：Clinical Research<br>经验分享：8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下，觉得我们的abstract写的不够吸引人，可能没有引起editor的注意，然后提交了resubmission，相当于appeal against the intial editorial decision，意思就是说我们的研究还是值得你们仔细看一看 （目前在五大临床刊里只有BMJ提供这个选项，不要轻易使用，只有当你有理由认为你的研究值得BMJ发表的情况下再使用）。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见，比如reviewer认为你的研究不应该被收录，但给的理由不对，这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低，BMJ也不推荐。幸运的是在我们appeal了以后，另一个editor给了positive的意见，然后文章进入了external review阶段（给editor点个赞）。<br>找reviewer一周，审稿两周，editorial decision又两周，10月初给了revision。Editor和reviewer都非常负责，9页纸的comments，花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态，一直是等待reviewer和editor的分配（怀疑工作人员休假去了）。12月初，正在我们各种吐槽这一轮为何如此之慢的时候，editor的邮件来了，给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些，不过他们会把editorial meeting对你的文章的comments都记录下来发给你，非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀（相对杂志的地位，估计大家都不会在意这个了哈哈）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203046, encodeId=2f0b120304603, content=咨询一个问题：British Medical Journal,Vol.366, l4898, 2019 这里的 l4898表示什么意思，不是第几期的意思吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=732, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9246554723, createdName=ms8000000162733123, createdTime=Wed Mar 16 11:08:08 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-07-05 138299b15em

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享：文章已接受，版面Endgames，请问大侠们Endgames版面从接受到proof需要多久啊？

    11

    展开11条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：文章已接受，版面Endgames，请问大侠们Endgames版面从接受到proof需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：方法学;临床流行病<br>经验分享：审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天，状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向：循证医学;流行病学<br>经验分享：投稿两个月了，还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享：已投七个月，返修两次，现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享：投稿两月余，这段时间awaiting reviewer scores后变成 with with committee for evaluation，后来两天又变成awaiting reviewer scores，大侠们知道什么情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿，邮件时间一个月，系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿，邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改，时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑，目前等待proof，感谢一起努力的三位伙伴，铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向：Clinical Research<br>经验分享：8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下，觉得我们的abstract写的不够吸引人，可能没有引起editor的注意，然后提交了resubmission，相当于appeal against the intial editorial decision，意思就是说我们的研究还是值得你们仔细看一看 （目前在五大临床刊里只有BMJ提供这个选项，不要轻易使用，只有当你有理由认为你的研究值得BMJ发表的情况下再使用）。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见，比如reviewer认为你的研究不应该被收录，但给的理由不对，这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低，BMJ也不推荐。幸运的是在我们appeal了以后，另一个editor给了positive的意见，然后文章进入了external review阶段（给editor点个赞）。<br>找reviewer一周，审稿两周，editorial decision又两周，10月初给了revision。Editor和reviewer都非常负责，9页纸的comments，花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态，一直是等待reviewer和editor的分配（怀疑工作人员休假去了）。12月初，正在我们各种吐槽这一轮为何如此之慢的时候，editor的邮件来了，给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些，不过他们会把editorial meeting对你的文章的comments都记录下来发给你，非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀（相对杂志的地位，估计大家都不会在意这个了哈哈）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203046, encodeId=2f0b120304603, content=咨询一个问题：British Medical Journal,Vol.366, l4898, 2019 这里的 l4898表示什么意思，不是第几期的意思吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=732, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9246554723, createdName=ms8000000162733123, createdTime=Wed Mar 16 11:08:08 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2023-07-04 122cba2dm74暂无昵称 来自安徽省

    审稿速度:6.0 | 投稿命中率:5.0
    偏重的研究方向：方法学;临床流行病
    经验分享：审稿严谨

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：文章已接受，版面Endgames，请问大侠们Endgames版面从接受到proof需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：方法学;临床流行病<br>经验分享：审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天，状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向：循证医学;流行病学<br>经验分享：投稿两个月了，还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享：已投七个月，返修两次，现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享：投稿两月余，这段时间awaiting reviewer scores后变成 with with committee for evaluation，后来两天又变成awaiting reviewer scores，大侠们知道什么情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿，邮件时间一个月，系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿，邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改，时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑，目前等待proof，感谢一起努力的三位伙伴，铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向：Clinical Research<br>经验分享：8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下，觉得我们的abstract写的不够吸引人，可能没有引起editor的注意，然后提交了resubmission，相当于appeal against the intial editorial decision，意思就是说我们的研究还是值得你们仔细看一看 （目前在五大临床刊里只有BMJ提供这个选项，不要轻易使用，只有当你有理由认为你的研究值得BMJ发表的情况下再使用）。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见，比如reviewer认为你的研究不应该被收录，但给的理由不对，这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低，BMJ也不推荐。幸运的是在我们appeal了以后，另一个editor给了positive的意见，然后文章进入了external review阶段（给editor点个赞）。<br>找reviewer一周，审稿两周，editorial decision又两周，10月初给了revision。Editor和reviewer都非常负责，9页纸的comments，花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态，一直是等待reviewer和editor的分配（怀疑工作人员休假去了）。12月初，正在我们各种吐槽这一轮为何如此之慢的时候，editor的邮件来了，给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些，不过他们会把editorial meeting对你的文章的comments都记录下来发给你，非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀（相对杂志的地位，估计大家都不会在意这个了哈哈）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203046, encodeId=2f0b120304603, content=咨询一个问题：British Medical Journal,Vol.366, l4898, 2019 这里的 l4898表示什么意思，不是第几期的意思吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=732, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9246554723, createdName=ms8000000162733123, createdTime=Wed Mar 16 11:08:08 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2023-01-26 罗 来自福建省

    投稿17天，状态变成With Committee for Evaluation

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：文章已接受，版面Endgames，请问大侠们Endgames版面从接受到proof需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：方法学;临床流行病<br>经验分享：审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天，状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向：循证医学;流行病学<br>经验分享：投稿两个月了，还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享：已投七个月，返修两次，现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享：投稿两月余，这段时间awaiting reviewer scores后变成 with with committee for evaluation，后来两天又变成awaiting reviewer scores，大侠们知道什么情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿，邮件时间一个月，系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿，邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改，时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑，目前等待proof，感谢一起努力的三位伙伴，铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向：Clinical Research<br>经验分享：8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下，觉得我们的abstract写的不够吸引人，可能没有引起editor的注意，然后提交了resubmission，相当于appeal against the intial editorial decision，意思就是说我们的研究还是值得你们仔细看一看 （目前在五大临床刊里只有BMJ提供这个选项，不要轻易使用，只有当你有理由认为你的研究值得BMJ发表的情况下再使用）。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见，比如reviewer认为你的研究不应该被收录，但给的理由不对，这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低，BMJ也不推荐。幸运的是在我们appeal了以后，另一个editor给了positive的意见，然后文章进入了external review阶段（给editor点个赞）。<br>找reviewer一周，审稿两周，editorial decision又两周，10月初给了revision。Editor和reviewer都非常负责，9页纸的comments，花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态，一直是等待reviewer和editor的分配（怀疑工作人员休假去了）。12月初，正在我们各种吐槽这一轮为何如此之慢的时候，editor的邮件来了，给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些，不过他们会把editorial meeting对你的文章的comments都记录下来发给你，非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀（相对杂志的地位，估计大家都不会在意这个了哈哈）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203046, encodeId=2f0b120304603, content=咨询一个问题：British Medical Journal,Vol.366, l4898, 2019 这里的 l4898表示什么意思，不是第几期的意思吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=732, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9246554723, createdName=ms8000000162733123, createdTime=Wed Mar 16 11:08:08 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-06-29 weilai2015

    偏重的研究方向：循证医学;流行病学
    经验分享：投稿两个月了，还在外审......

    17

    展开17条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：文章已接受，版面Endgames，请问大侠们Endgames版面从接受到proof需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：方法学;临床流行病<br>经验分享：审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天，状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向：循证医学;流行病学<br>经验分享：投稿两个月了，还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享：已投七个月，返修两次，现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享：投稿两月余，这段时间awaiting reviewer scores后变成 with with committee for evaluation，后来两天又变成awaiting reviewer scores，大侠们知道什么情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿，邮件时间一个月，系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿，邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改，时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑，目前等待proof，感谢一起努力的三位伙伴，铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向：Clinical Research<br>经验分享：8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下，觉得我们的abstract写的不够吸引人，可能没有引起editor的注意，然后提交了resubmission，相当于appeal against the intial editorial decision，意思就是说我们的研究还是值得你们仔细看一看 （目前在五大临床刊里只有BMJ提供这个选项，不要轻易使用，只有当你有理由认为你的研究值得BMJ发表的情况下再使用）。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见，比如reviewer认为你的研究不应该被收录，但给的理由不对，这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低，BMJ也不推荐。幸运的是在我们appeal了以后，另一个editor给了positive的意见，然后文章进入了external review阶段（给editor点个赞）。<br>找reviewer一周，审稿两周，editorial decision又两周，10月初给了revision。Editor和reviewer都非常负责，9页纸的comments，花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态，一直是等待reviewer和editor的分配（怀疑工作人员休假去了）。12月初，正在我们各种吐槽这一轮为何如此之慢的时候，editor的邮件来了，给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些，不过他们会把editorial meeting对你的文章的comments都记录下来发给你，非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀（相对杂志的地位，估计大家都不会在意这个了哈哈）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203046, encodeId=2f0b120304603, content=咨询一个问题：British Medical Journal,Vol.366, l4898, 2019 这里的 l4898表示什么意思，不是第几期的意思吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=732, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9246554723, createdName=ms8000000162733123, createdTime=Wed Mar 16 11:08:08 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-07-20 ms9000001765004289

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：投了一个月 说我需要润色 英语太差拒稿

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：文章已接受，版面Endgames，请问大侠们Endgames版面从接受到proof需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：方法学;临床流行病<br>经验分享：审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天，状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向：循证医学;流行病学<br>经验分享：投稿两个月了，还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享：已投七个月，返修两次，现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享：投稿两月余，这段时间awaiting reviewer scores后变成 with with committee for evaluation，后来两天又变成awaiting reviewer scores，大侠们知道什么情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿，邮件时间一个月，系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿，邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改，时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑，目前等待proof，感谢一起努力的三位伙伴，铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向：Clinical Research<br>经验分享：8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下，觉得我们的abstract写的不够吸引人，可能没有引起editor的注意，然后提交了resubmission，相当于appeal against the intial editorial decision，意思就是说我们的研究还是值得你们仔细看一看 （目前在五大临床刊里只有BMJ提供这个选项，不要轻易使用，只有当你有理由认为你的研究值得BMJ发表的情况下再使用）。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见，比如reviewer认为你的研究不应该被收录，但给的理由不对，这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低，BMJ也不推荐。幸运的是在我们appeal了以后，另一个editor给了positive的意见，然后文章进入了external review阶段（给editor点个赞）。<br>找reviewer一周，审稿两周，editorial decision又两周，10月初给了revision。Editor和reviewer都非常负责，9页纸的comments，花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态，一直是等待reviewer和editor的分配（怀疑工作人员休假去了）。12月初，正在我们各种吐槽这一轮为何如此之慢的时候，editor的邮件来了，给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些，不过他们会把editorial meeting对你的文章的comments都记录下来发给你，非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀（相对杂志的地位，估计大家都不会在意这个了哈哈）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203046, encodeId=2f0b120304603, content=咨询一个问题：British Medical Journal,Vol.366, l4898, 2019 这里的 l4898表示什么意思，不是第几期的意思吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=732, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9246554723, createdName=ms8000000162733123, createdTime=Wed Mar 16 11:08:08 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-03-19 yinahao

    投稿命中率:5.0
    经验分享：已投七个月，返修两次，现在状态又重来一遍

    10

    展开10条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：文章已接受，版面Endgames，请问大侠们Endgames版面从接受到proof需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：方法学;临床流行病<br>经验分享：审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天，状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向：循证医学;流行病学<br>经验分享：投稿两个月了，还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享：已投七个月，返修两次，现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享：投稿两月余，这段时间awaiting reviewer scores后变成 with with committee for evaluation，后来两天又变成awaiting reviewer scores，大侠们知道什么情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿，邮件时间一个月，系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿，邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改，时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑，目前等待proof，感谢一起努力的三位伙伴，铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向：Clinical Research<br>经验分享：8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下，觉得我们的abstract写的不够吸引人，可能没有引起editor的注意，然后提交了resubmission，相当于appeal against the intial editorial decision，意思就是说我们的研究还是值得你们仔细看一看 （目前在五大临床刊里只有BMJ提供这个选项，不要轻易使用，只有当你有理由认为你的研究值得BMJ发表的情况下再使用）。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见，比如reviewer认为你的研究不应该被收录，但给的理由不对，这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低，BMJ也不推荐。幸运的是在我们appeal了以后，另一个editor给了positive的意见，然后文章进入了external review阶段（给editor点个赞）。<br>找reviewer一周，审稿两周，editorial decision又两周，10月初给了revision。Editor和reviewer都非常负责，9页纸的comments，花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态，一直是等待reviewer和editor的分配（怀疑工作人员休假去了）。12月初，正在我们各种吐槽这一轮为何如此之慢的时候，editor的邮件来了，给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些，不过他们会把editorial meeting对你的文章的comments都记录下来发给你，非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀（相对杂志的地位，估计大家都不会在意这个了哈哈）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203046, encodeId=2f0b120304603, content=咨询一个问题：British Medical Journal,Vol.366, l4898, 2019 这里的 l4898表示什么意思，不是第几期的意思吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=732, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9246554723, createdName=ms8000000162733123, createdTime=Wed Mar 16 11:08:08 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-03-22 138299b15em

    审稿速度:3.0
    经验分享：投稿两月余，这段时间awaiting reviewer scores后变成 with with committee for evaluation，后来两天又变成awaiting reviewer scores，大侠们知道什么情况吗？

    6

    展开6条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：文章已接受，版面Endgames，请问大侠们Endgames版面从接受到proof需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：方法学;临床流行病<br>经验分享：审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天，状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向：循证医学;流行病学<br>经验分享：投稿两个月了，还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享：已投七个月，返修两次，现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享：投稿两月余，这段时间awaiting reviewer scores后变成 with with committee for evaluation，后来两天又变成awaiting reviewer scores，大侠们知道什么情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿，邮件时间一个月，系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿，邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改，时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑，目前等待proof，感谢一起努力的三位伙伴，铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向：Clinical Research<br>经验分享：8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下，觉得我们的abstract写的不够吸引人，可能没有引起editor的注意，然后提交了resubmission，相当于appeal against the intial editorial decision，意思就是说我们的研究还是值得你们仔细看一看 （目前在五大临床刊里只有BMJ提供这个选项，不要轻易使用，只有当你有理由认为你的研究值得BMJ发表的情况下再使用）。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见，比如reviewer认为你的研究不应该被收录，但给的理由不对，这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低，BMJ也不推荐。幸运的是在我们appeal了以后，另一个editor给了positive的意见，然后文章进入了external review阶段（给editor点个赞）。<br>找reviewer一周，审稿两周，editorial decision又两周，10月初给了revision。Editor和reviewer都非常负责，9页纸的comments，花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态，一直是等待reviewer和editor的分配（怀疑工作人员休假去了）。12月初，正在我们各种吐槽这一轮为何如此之慢的时候，editor的邮件来了，给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些，不过他们会把editorial meeting对你的文章的comments都记录下来发给你，非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀（相对杂志的地位，估计大家都不会在意这个了哈哈）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203046, encodeId=2f0b120304603, content=咨询一个问题：British Medical Journal,Vol.366, l4898, 2019 这里的 l4898表示什么意思，不是第几期的意思吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=732, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9246554723, createdName=ms8000000162733123, createdTime=Wed Mar 16 11:08:08 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2020-08-01 krygios

    替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿，邮件时间一个月，系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿，邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改，时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑，目前等待proof，感谢一起努力的三位伙伴，铭记一起走过的投稿煎熬

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：文章已接受，版面Endgames，请问大侠们Endgames版面从接受到proof需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：方法学;临床流行病<br>经验分享：审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天，状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向：循证医学;流行病学<br>经验分享：投稿两个月了，还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享：已投七个月，返修两次，现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享：投稿两月余，这段时间awaiting reviewer scores后变成 with with committee for evaluation，后来两天又变成awaiting reviewer scores，大侠们知道什么情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿，邮件时间一个月，系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿，邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改，时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑，目前等待proof，感谢一起努力的三位伙伴，铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向：Clinical Research<br>经验分享：8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下，觉得我们的abstract写的不够吸引人，可能没有引起editor的注意，然后提交了resubmission，相当于appeal against the intial editorial decision，意思就是说我们的研究还是值得你们仔细看一看 （目前在五大临床刊里只有BMJ提供这个选项，不要轻易使用，只有当你有理由认为你的研究值得BMJ发表的情况下再使用）。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见，比如reviewer认为你的研究不应该被收录，但给的理由不对，这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低，BMJ也不推荐。幸运的是在我们appeal了以后，另一个editor给了positive的意见，然后文章进入了external review阶段（给editor点个赞）。<br>找reviewer一周，审稿两周，editorial decision又两周，10月初给了revision。Editor和reviewer都非常负责，9页纸的comments，花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态，一直是等待reviewer和editor的分配（怀疑工作人员休假去了）。12月初，正在我们各种吐槽这一轮为何如此之慢的时候，editor的邮件来了，给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些，不过他们会把editorial meeting对你的文章的comments都记录下来发给你，非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀（相对杂志的地位，估计大家都不会在意这个了哈哈）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203046, encodeId=2f0b120304603, content=咨询一个问题：British Medical Journal,Vol.366, l4898, 2019 这里的 l4898表示什么意思，不是第几期的意思吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=732, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9246554723, createdName=ms8000000162733123, createdTime=Wed Mar 16 11:08:08 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2020-12-05 ms1000001266658240

    审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0
    偏重的研究方向：Clinical Research
    经验分享：8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下，觉得我们的abstract写的不够吸引人，可能没有引起editor的注意，然后提交了resubmission，相当于appeal against the intial editorial decision，意思就是说我们的研究还是值得你们仔细看一看 （目前在五大临床刊里只有BMJ提供这个选项，不要轻易使用，只有当你有理由认为你的研究值得BMJ发表的情况下再使用）。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见，比如reviewer认为你的研究不应该被收录，但给的理由不对，这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低，BMJ也不推荐。幸运的是在我们appeal了以后，另一个editor给了positive的意见，然后文章进入了external review阶段（给editor点个赞）。
    找reviewer一周，审稿两周，editorial decision又两周，10月初给了revision。Editor和reviewer都非常负责，9页纸的comments，花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态，一直是等待reviewer和editor的分配（怀疑工作人员休假去了）。12月初，正在我们各种吐槽这一轮为何如此之慢的时候，editor的邮件来了，给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。
    BMJ的速度相对JAMA来说慢一些，不过他们会把editorial meeting对你的文章的comments都记录下来发给你，非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀（相对杂志的地位，估计大家都不会在意这个了哈哈）。

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1230747, encodeId=5b591230e477a, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：文章已接受，版面Endgames，请问大侠们Endgames版面从接受到proof需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Jul 05 19:04:21 CST 2022, time=2022-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146264, encodeId=bfa12146264da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：方法学;临床流行病<br>经验分享：审稿严谨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a7a2359759, createdName=122cba2dm74暂无昵称, createdTime=Tue Jul 04 11:39:24 CST 2023, time=2023-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2111499, encodeId=cce32111499b2, content=投稿17天，状态变成With Committee for Evaluation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a0eb5513755, createdName=罗, createdTime=Thu Jan 26 11:59:47 CST 2023, time=2023-01-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=1229462, encodeId=e0e4122946215, content=偏重的研究方向：循证医学;流行病学<br>经验分享：投稿两个月了，还在外审......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/02/d37962662c9a26e598b3a66205ffa861.jpg, createdBy=db751656082, createdName=weilai2015, createdTime=Wed Jun 29 14:11:22 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233647, encodeId=ddcc123364eec, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：投了一个月 说我需要润色 英语太差拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ace5416424, createdName=ms9000001765004289, createdTime=Wed Jul 20 16:22:08 CST 2022, time=2022-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204161, encodeId=c86112041611a, content=投稿命中率:5.0<br>经验分享：已投七个月，返修两次，现在状态又重来一遍, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101e65534, createdName=yinahao, createdTime=Sat Mar 19 19:22:06 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205060, encodeId=94c6120506075, content=审稿速度:3.0<br>经验分享：投稿两月余，这段时间awaiting reviewer scores后变成 with with committee for evaluation，后来两天又变成awaiting reviewer scores，大侠们知道什么情况吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83223009577, createdName=138299b15em, createdTime=Tue Mar 22 22:42:24 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805613, encodeId=5b3c80561369, content=替整个团队记录一下 2020.01.07 投稿 2020.03.01 通知修稿，邮件时间一个月，系统三个月 2020.04.01 第一次修回 2020.04.27 通知修稿，邮件和系统时间均一个月 2020.05.12 第二次修回 2020.07.01 通知修改，时间一个月 2020.07.03 第三次修回 2020.07.17 原则接收 2020.07.19 第四次修回 2020.07.26 正式接收 2020.07.31 寄给编辑文章相关的bmj opinion 版面费3000英镑，目前等待proof，感谢一起努力的三位伙伴，铭记一起走过的投稿煎熬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Aug 01 16:12:07 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905193, encodeId=fed99051933d, content=审稿速度:1.0 | 投稿命中率:25.0 | 版面费用:4800.0<br>偏重的研究方向：Clinical Research<br>经验分享：8月3日投稿BMJ的research section。两天秒拒。跟其他作者商议了一下，觉得我们的abstract写的不够吸引人，可能没有引起editor的注意，然后提交了resubmission，相当于appeal against the intial editorial decision，意思就是说我们的研究还是值得你们仔细看一看 （目前在五大临床刊里只有BMJ提供这个选项，不要轻易使用，只有当你有理由认为你的研究值得BMJ发表的情况下再使用）。BMJ的网站上明确说了这个功能比较多用于反驳reviewer的意见，比如reviewer认为你的研究不应该被收录，但给的理由不对，这种情况下可以appeal。但是对于editoral decision这个appeal的功能成功率极低，BMJ也不推荐。幸运的是在我们appeal了以后，另一个editor给了positive的意见，然后文章进入了external review阶段（给editor点个赞）。<br>找reviewer一周，审稿两周，editorial decision又两周，10月初给了revision。Editor和reviewer都非常负责，9页纸的comments，花了整一个月来修改和补数据。11月初提交revision。中间不知道为何系统没有更新状态，一直是等待reviewer和editor的分配（怀疑工作人员休假去了）。12月初，正在我们各种吐槽这一轮为何如此之慢的时候，editor的邮件来了，给了provisional accpetance。48小时修改格式。三天以后给了final acceptance。<br>BMJ的速度相对JAMA来说慢一些，不过他们会把editorial meeting对你的文章的comments都记录下来发给你，非常有帮助。总体来说感觉很不错。BMJ的research section的Open Access 4800刀（相对杂志的地位，估计大家都不会在意这个了哈哈）。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86a45441685, createdName=ms1000001266658240, createdTime=Sat Dec 05 15:37:37 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203046, encodeId=2f0b120304603, content=咨询一个问题：British Medical Journal,Vol.366, l4898, 2019 这里的 l4898表示什么意思，不是第几期的意思吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=732, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9246554723, createdName=ms8000000162733123, createdTime=Wed Mar 16 11:08:08 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-03-16 ms8000000162733123

    咨询一个问题：British Medical Journal,Vol.366, l4898, 2019 这里的 l4898表示什么意思，不是第几期的意思吧

    0

共109条页码: 1/11页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分